Le Lézard
Classified in: Science and technology
Subject: CCA

Valens Semiconductor to Participate in Upcoming Investor Conferences


HOD HASHARON, Israel, May 2, 2024 /PRNewswire/ -- Valens Semiconductor (NYSE: VLN), a leader in high-performance connectivity, today announced that it will participate in the following investor events in May 2024.

Valens Semiconductor

Oppenheimer 9th Annual Emerging Growth Conference (Virtual): On Thursday, May 9, 2024. Guy Nathanzon, CFO of Valens Semiconductor, will participate in one-on-one meetings.

Oppenheimer 25th Annual Israeli Conference: On Sunday, May 26, 2024. Guy Nathanzon will be presenting at 12:50 PM Israel Time. Nathanzon will also be available for one-on-one and small group meetings throughout the day. The conference will be held in Tel Aviv, Israel.

For more information about the events or questions about registration, interested parties should reach out to their contacts at Oppenheimer.

About Valens Semiconductor

Valens Semiconductor (NYSE:VLN) is a leader in high-performance connectivity, enabling customers to transform the digital experiences of people worldwide. Valens' chipsets are integrated into countless devices from leading customers, powering state-of-the-art audio-video installations, next-generation videoconferencing, and enabling the evolution of ADAS and autonomous driving. Pushing the boundaries of connectivity, Valens sets the standard everywhere it operates, and its technology forms the basis for the leading industry standards such as HDBaseT® and MIPI A-PHY. For more information, visit https://www.valens.com/.

Valens Semiconductor

Investor Contact:

Lisa Fortuna
Financial Profiles, Inc.
[email protected]

Logo - https://mma.prnewswire.com/media/2309625/4474760/Valens_Semiconductor_Logo.jpg

SOURCE Valens Semiconductor


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

18 mai 2024
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: